Cytotoxic Dehydroabietylamine Derived Compounds

Author:

Wiemann Jana1ORCID,Al-Harrasi Ahmed2ORCID,Csuk René1ORCID

Affiliation:

1. Martin-Luther-University Halle-Wittenberg, Organic Chemistry, Kurt-Mothes-Str. 2, D-06120 Halle (Saale), Germany

2. University of Nizwa, Chair of Oman’s Medicinal Plants and Marine Natural Products, P.O. Box 33, PC 616, Birkat Al-Mauz, Nizwa, Oman

Abstract

Background and Methods: Chemotherapy remains one of the most important methods for the treatment of cancer. More recently in this context, some products derived from natural products have raised scientific interest which especially include many terpenes. Thereby, diterpenoids represent a special class, and within this class of important secondary natural products, especially compounds derived from Dehydroabietylamine (DA), are of particular interest. Results: This review not only gives a summary of the most important findings on the cytotoxic behavior of DAderived compounds but also shows some drawbacks of these compounds, such low bioavailability and/or poor solubility of several derivatives of DA. It focusses on the chemical aspects and summarizes the DA related biological effects without deep discussion of underlying biochemical pathways. Conclusion: Dehydroabietylamine-derived cytotoxic compounds hold a high potential to be developed into efficient antitumor active drugs.

Publisher

Bentham Science Publishers Ltd.

Subject

Cancer Research,Pharmacology,Molecular Medicine

Reference114 articles.

1. Aigner, K.R.; Stephens, F.O.; Allen-Mersh, T.; Hortobagyi, G.; Khayat, D.; Picksley, S.M.; Sugarbaker, P.; Taguchi, T.; Thompson, J.F. Was ist eine maligne Erkrankung. In: Onkologie Basiswissen; Aigner, K.R.; Stephens, F.O., Eds.; Springer: Berlin, Heidelberg, 2016, pp. 3-13

2. Muller-Esterl, W. Molekulare Basis von Krebsentstehung und Krebsbekampfung. In: Biochemie: Eine Einfuhrung fur Mediziner und Naturwissenschaftler; Muller-Esterl, W., Ed.; Springer: Berlin, Heidelberg, 2018, pp. 527-548.

3. Bohm R.; Cimin-Bredee N.; Culman J.; Gohlke P.; Ley L.; Luippold G.; Ufer M.; Watzig V.; Pharmakotherapie von Tumoren. In Pharmakotherapie: Klinische Pharmakologie Lemmer, B.; Brune, K., Eds.; Springer: Berlin, Heidelberg., 2010, pp., 155-166.

4. Fromm M.F.; Gramatzki M.; Pharmakotherapie von Tumoren. In Pharmakotherapie: Klinische Pharmakologie Lemmer, B.; Brune, K., Eds.; Springer: Berlin, Heidelberg., 2010, pp. 155-166.

5. Samuelsson G.; Drugs of Natural Origin: A Textbook of PharmacognosySwedish Pharmaceutical Press: Stockholm 1999

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3